An attempt of elaboration of experimental model of hepatorenal syndrome in Wistar rats;Próba opracowania doświadczalnego modelu zespołu wa̧trobowo-nerkowego u szczurów rasy Wistar

Polski Merkuriusz Lekarski

Volumn 17, Issue 98, 2004, Pages 119-122

  Saracyn, Marek ^a   Kozłowski, Wojciech ^a   Wańkowicz, Zofia ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Experimental model; Hepatorenal syndrome; Wistar rats

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GALACTOSAMINE;

ACUTE KIDNEY FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; GENETIC PREDISPOSITION; HEPATORENAL SYNDROME; LIVER INJURY; LIVER NECROSIS; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; RAT STRAIN; RISK FACTOR; UREA BLOOD LEVEL;

ALANINE TRANSAMINASE; AMMONIA; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DISEASE MODELS, ANIMAL; GALACTOSAMINE; HEPATOCYTES; HEPATORENAL SYNDROME; KIDNEY; LIVER FAILURE; MALE; RATS; RATS, WISTAR;

EID: 4644361225     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Anand R., Harry D., Holt S. i wsp.: Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut, 2002, 50, 111-117.
2. Arroyo V., Gines P., Gerbes A. i wsp.: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996, 23, 164-176.
3. Battaler R., Gines P., Guevara M. i wsp.: Hepatorenal syndrome. Sem. Liv. Dis., 1997, 17, 3, 233-248.
4. Brzozowski R.: Zespół wa̧trobowo-nerkowy. W: Choroby wa̧troby i dró żółciowych. (red. Brzozowski R.). PZWL. Warszawa. 1991.
5. Claria J., Jimenez W., Ros J. i wsp.: Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology, 1992, 15, 343-349.
6. Epstein M., Berck D.P., Hollemberg N.K. i wsp.: Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am. J. Med., 1970, 49, 175-185.
7. Flint A.: Clinical report on hydro-peritoneum, based on an analysis of forty-six cases. Am. J. Med. Sci., 1863, 45, 306-339.
8. Gines P., Arroyo V.: Hepatorenal syndrome. J. Am. Soc. Nephrol., 1999, 10, 1833-1839.
9. Ingles A.C., Hernandez I., Garcia-Estan J.: Increased total vascular capacity in conscious cirrhotic rats. Gastroenterology, 1992, 103, 275-281.
10. Javle P., Yates J., Kynaston H.G. i wsp.: Hepatosplanchnic hemodynamic and renal blood flow and function in rats with liver failure. Gut, 1998, 43, 272-279.
11. Keppler D. i wsp.: Experimental hepatitis induced by D-galactosamine. Exp. Mol. Pathol., 1968, 9, 279-290.
12. Levy M.: Hepatorenal syndrome. Kidney Int., 1993, 43, 737-753.
13. Levy M., Finestone H.: Renal response to four hours of biliary obstruction in the dog. Am. J. Pnysiol., 1983, 244, F516-525.
14. Lopez-Novoa J.M.: Pathophysiological features of the carbon tetrachloride/phenobarbital model of experimental liver ciihosis. In: The kidney in liver disease, (ed. Epstein M.). Wiliams&Wilkins. Baltimore. 1988.
15. Makin A.J., Hughes R.D., Wiliams R.: Systemic and hepatic hemodynamic changes in acute liver injury. Am. J. Physiol., 1997, 272, G617-625.
16. Martin P.Y., Gines P., Schrier R.W.: Role of nitric oxide as mediator of hemodynamic abnormalities and sodium and water retension in cirrhosis. N. Engl. J. Med., 1998, 339, 533-541.
17. Proctor E., Chatamra K.: High yield micronodular cirrhosis in the rat. Gastroenterology, 1982, 83, 1183-1190.